Research Study Evaluating a Novel PTSD Therapy

About the Study

This study is evaluating an investigational medicine that may help reduce symptoms of Post Traumatic Stress Disorder (PTSD) in adults.

PTSD can affect emotional wellbeing, stress responses, daily functioning, and quality of life. Researchers are exploring whether this investigational medicine may help regulate biological stress response pathways involved in trauma and improve symptoms associated with PTSD.

The study will evaluate how safe and well-tolerated the investigational medicine is and whether it may improve PTSD symptoms and overall functioning.

Who Can Participate

• Aged 18–65
• You have been diagnosed with PTSD
• You have been stable on your current medication or therapy for at least 2 months
• You are willing to attend scheduled study visits and assessments
• You are able to commit to the full study duration (approximately 13 weeks)

What to Expect During Study Participation

If eligible, you will take part in the study for up to approximately 13 weeks, including screening, treatment, and follow-up. The study involves six clinic visits, with regular health and mental health assessments throughout the study period. Visits will need to be completed during our clinic business hours of Monday to Friday, 9am–5pm.

During the study, you will take a once-daily oral tablet containing either the investigational medicine or a placebo. Throughout the study, doctors will closely monitor your PTSD symptoms, overall wellbeing, and safety through regular check-ups and assessments. Each clinic visit will vary in duration. At these visits, you may undergo several health assessments, which may include physical examinations, vital signs checks, ECGs, blood tests, and mental health questionnaires.